Clinical trial · Observational
Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
NCT07334314CI-TRIAL-00100599OUAFrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to estimate the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained in this practice.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Urothelial Carcinoma | Urothelial Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| olfactory detection by dogs | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Positive bladder tumor
- description
- Bladder tumor present during cystoscopy and confirmed by pathological examination.
- interventionNames
- Diagnostic Test: olfactory detection by dogs
- label
- Negative bladder tumor
- description
- No bladder tumor on cystoscopy/suspicious lesion but with negative pathological analysis
- interventionNames
- Diagnostic Test: olfactory detection by dogs
Primary outcomes (1)
- measure
- Assess the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained for this purpose
- timeFrame
- Day -60 to Day 0
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult (\> 18 years old) * Subject scheduled for any endourological surgery involving an initial cystoscopy, the most common of which are: transurethral resection of the bladder, transurethral resection of the prostate, internal optical urethrotomy, bladder lithoclast, ureteral stent replacement, ureteroscopy, etc. (non-exhaustive list) * Subjects for whom a urine sample (for bacteriological or cytological testing) is planned as part of routine practice in the month prior to the procedure * Subjects affiliated with a health insurance plan or beneficiaries of such a plan Exclusion Criteria: * Absence of signed informed consent / inability to provide the subject with informed information (emergency situations, difficulties in understanding the subject, etc.) * Patient under guardianship, conservatorship, or judicial protection * History of cancer other than urothelial bladder carcinoma, unless in complete remission for \> 5 years * Pregnant or breastfeeding women
References
Publications (0)
Data not yet available
No reference posted for this study.